MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
H.R./S.1: Tax Cuts and Jobs Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CLAIRE WILLIS BRANDEWIE | — |
| JOSEPH M GANLEY | — |
| PETER SLONE | — |
Veterans VET
Issues related to reimbursement from the Department of Veterans Affairs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BEN JONES | — |
| KATIE JONES | — |
| LISA LANGENDERFER | — |
Health Issues HCR
Implementation of Comprehensive Addiction and Recovery Act (CARA) PL 114-198 and education regarding opioid treatment and prevention; Implementation of 21st Century Cures (H.R. 34), advocacy related to healthcare technology and innovation issues; E-Rx (H.R.3528), advocacy related to electronic prescriptions of medications; Implementation of FY'2018 NDAA provision related to e-Commerce portals; education about potential improvements to Prescription Drug Monitoring Programs; H.R. 6 Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CLAIRE WILLIS BRANDEWIE | — |
| JOSEPH M GANLEY | — |
| PETER SLONE | — |
Medicare/Medicaid MMM
Physician and pharmacy reimbursement issues; Legislation to amend Part B of title XVII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biological under Medicare; Site neutral payment reforms; Issues related to physician reimbursement for Part B drugs; Support for increased transparency and accountability in Medicare's local determination process (S.794/H.R. 3635); Issues as they relate to opioid abuse policy; General Medicare/Medicaid Issues; Issues related to reimbursement for radiation therapy services; 340B, education related to need for sensible reforms in 340B that protect indigent beneficiaries and community oncology practices; Pandemic and All Hazards Preparedness Act reauthorization; issues related to step therapy policies in Medicare Advantage plans; Medicare physician payment.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CLAIRE WILLIS BRANDEWIE | — |
| JOSEPH M GANLEY | — |
| BEN JONES | — |
| KATIE JONES | — |
| LISA LANGENDERFER | — |
| PETER SLONE | — |
Pharmacy PHA
Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion; support for legislation to preserve patient access to oral oncolytics dispensed by community-based cancer clinics (H.R. 1316); DIR (H.R. 1038), advocacy related to ending retroactive direct and indirect renumeration fees levied on pharmacists; Provider status (H.R. 592), advocacy related to recognizing and reimbursing pharmacists for providing appropriate medical services; H.R. 6688, The Analyzing and Leveraging Existing Rx Transactions (ALERT) Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CLAIRE WILLIS BRANDEWIE | — |
| JOSEPH M GANLEY | — |
| BEN JONES | — |
| KATIE JONES | — |
| LISA LANGENDERFER | — |
| PETER SLONE | — |
Tariff (miscellaneous tariff bills) TAR
USTR Section 301 proposed tariffs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CLAIRE WILLIS BRANDEWIE | — |
| JOSEPH M GANLEY | — |
| PETER SLONE | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.